From July 1, 2023 to September 20, 2023, the company has repurchased 7,669,100 shares, representing 0.64% for CNY 81.02 million. With this, the company has completed the repurchase of 18,489,100 shares, representing 1.55% for CNY 194.73 million under the buyback announced on September 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 CNY | +3.29% | +9.68% | -12.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 1.34B | |
+33.48% | 704B | |
+28.59% | 577B | |
-4.02% | 348B | |
+18.60% | 327B | |
+4.83% | 288B | |
+14.70% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.06% | 147B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.